000 06302cam a2200829Ia 4500
001 sulb-eb0032385
003 BD-SySUS
005 20170713221330.0
006 m o d
007 cr cnu|||unuuu
008 130305s2013 gw ob 001 0 eng d
040 _aN$T
_beng
_epn
_cN$T
_dE7B
_dDG1
_dCUS
_dNOC
_dOCLCO
_dYDXCP
_dOCLCA
_dNLGGC
_dOCLCF
_dEBLCP
_dUKMGB
_dIDEBK
_dDEBBG
_dOCLCQ
_dCOO
_dNKT
_dBD-SySUS
016 7 _a016300416
_2Uk
019 _a829460534
_a961671411
_a962584608
020 _a9783527670420
_q(electronic bk.)
020 _a3527670424
_q(electronic bk.)
020 _a9783527670437
_q(electronic bk.)
020 _a3527670432
_q(electronic bk.)
020 _z9783527324569
029 1 _aAU@
_b000051628906
029 1 _aAU@
_b000053032883
029 1 _aCHBIS
_b010026927
029 1 _aCHVBK
_b306231786
029 1 _aDEBBG
_bBV041069692
029 1 _aDEBBG
_bBV041911234
029 1 _aDKDLA
_b820120-katalog:000655911
029 1 _aNLGGC
_b372651682
029 1 _aNZ1
_b15340142
029 1 _aDEBBG
_bBV043395562
035 _a(OCoLC)828933132
_z(OCoLC)829460534
_z(OCoLC)961671411
_z(OCoLC)962584608
050 4 _aQR76.6
072 7 _aNAT
_x022000
_2bisacsh
082 0 4 _a589.908734
_223
049 _aMAIN
245 0 0 _aMinicircle and Miniplasmid DNA Vectors :
_bThe Future of Nonviral and Viral Gene Transfer /
_cedited by Martin Schleef.
260 _aWeinheim, Germany :
_bWiley-Blackwell,
_c©2013.
300 _a1 online resource (xxi, 235 pages)
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
504 _aIncludes bibliographical references and index.
588 0 _aPrint version record.
505 0 _aMinicircle and Miniplasmid DNA Vectors: The Future of Non-Viral and Viral Gene Transfer; Contents; List of Contributors; Perface; 1 Minicircle Patents: A Short IP Overview of Optimizing Nonviral DNA Vectors; 2 Operator-Repressor Titration: Stable Plasmid Maintenance without Selectable Marker Genes; 2.1 Introduction; 2.2 Antibiotics and Metabolic Burden; 2.3 The Mechanism of ORT; 2.4 ORT Strain Development; 2.5 ORT Miniplasmids; 2.6 DNA Vaccine and Gene Therapy Vectors; 2.7 ORT-VAC: Plasmid-Based Vaccine Delivery Using Salmonella enterica; 2.8 Recombinant Protein Expression.
505 8 _a2.9 Conclusions and Future DevelopmentsReferences; 3 Selection by RNA-RNA Interaction: Maximally Minimized Antibiotic Resistance-Free Plasmids; 3.1 Gene Therapy and DNA Vaccines: Emerging Technologies; 3.1.1 Therapeutic Plasmids: General Design Principles; 3.2 Therapeutic Plasmids: Novel Design and the Problem of Selection; 3.2.1 Replication Control of ColE1-Type Plasmids as an Alternative Selection Marker; 3.2.2 The MINIback Concept: Selection by RNA-RNA Interaction; 3.2.3 Improved Production Processes by MINIback Plasmids; 3.2.4 Improving Sequence Composition; 3.2.5 Efficient Gene Transfer.
505 8 _a3.3 ConclusionsAcknowledgments; References; 4 Plasmid-Based Medicinal Products -- Focus on pFAR: A Miniplasmid Free of Antibiotic Resistance Markers; 4.1 Introduction: Rationale for the Development of Biosafe DNA Plasmid Vectors; 4.2 Specific Requirements for the Use of DNA Product as Medicines; 4.2.1 Requirements for Plasmid Quality and Purity; 4.2.2 Requirements for the Removal of Antibiotic Resistance Markers from Plasmid DNA; 4.2.2.1 Requirements for Biosafe Plasmids; 4.2.2.2 Positive Impact on the Removal of Antibiotic Resistance Markers.
505 8 _a4.2.2.3 Effect of Plasmid Size on Gene Transfer Efficiency In Vitro and In Vivo4.3 Nonviral Gene Vectors Devoid of Antibiotic Resistance Markers; 4.3.1 Generalities; 4.3.2 Selection Systems Devoid of Antibiotic Resistance Markers; 4.3.2.1 Complementation of Host Auxotrophy by a Function-Encoded Plasmid; 4.3.2.2 The Operator-Repressor Titration (ORT) System; 4.3.2.3 Protein-Based Antidote/Poison Selection Systems; 4.3.2.4 RNA-Based Selection Marker; 4.3.2.5 Suppression of a Nonsense Mutation; 4.4 The pFAR Plasmid Family; 4.4.1 Description of the Antibiotic-Free Selection System.
505 8 _a4.4.2 pFAR Vectors Promote Efficient Expression in Several Types of Mammalian Cells4.4.2.1 In Vitro Transfection Study; 4.4.2.2 In Vivo Transfection Studies; 4.4.3 Concluding Remarks on the pFAR4 Biosafe Miniplasmid; 4.5 Concluding Remarks and Perspectives; Acknowledgments; References; 5 Plasmid DNA Concatemers: Influence of Plasmid Structure on Transfection Efficiency; 5.1 Introduction; 5.2 Plasmid DNA Topology and Size; 5.3 Plasmid DNA Concatemers; 5.4 Conclusions; Acknowledgments; References; 6 Analytical Tools in Minicircle Production; 6.1 Introduction.
520 _aThis first title on the topic provides complete coverage, including the molecular basis, production and possible biomedical applications. Written by the most prominent academic researchers in the field as well as by researchers at one of the world's leading companies in industrial production of minicircle DNA, this practical book is aimed at everyone who is directly or indirectly involved in the development of gene therapies.
650 0 _aPlasmids
_xGenetics.
650 0 _aGenetic engineering.
650 2 _aPlasmids.
650 4 _aGene therapy.
650 4 _aGenetic engineering.
650 4 _aPlasmids
_xGenetics.
650 7 _aNATURE
_xPlants
_xMushrooms.
_2bisacsh
650 7 _aGenetic engineering.
_2fast
_0(OCoLC)fst00940027
650 7 _aPlasmids
_xGenetics.
_2fast
_0(OCoLC)fst01066381
655 4 _aElectronic books.
655 7 _aElectronic books.
_2local
700 1 _aSchleef, M.
_q(Martin)
776 0 8 _iPrint version:
_tMinicircle and miniplasmid DNA vectors.
_dWeinheim, Germany : Wiley-Blackwell, ©2013
_z9783527324569
856 4 0 _uhttp://onlinelibrary.wiley.com/book/10.1002/9783527670420
_zWiley Online Library [Free Download only for SUST IP]
938 _aEBL - Ebook Library
_bEBLB
_nEBL4044501
938 _aEBL - Ebook Library
_bEBLB
_nEBL1129769
938 _aebrary
_bEBRY
_nebr10662568
938 _aEBSCOhost
_bEBSC
_n542862
938 _aIngram Digital eBook Collection
_bIDEB
_ncis24876727
938 _aYBP Library Services
_bYANK
_n10247717
938 _aYBP Library Services
_bYANK
_n10350847
938 _aYBP Library Services
_bYANK
_n12679557
994 _a92
_bDG1
999 _c64037
_d64037